Health Care & Life Sciences » Biotechnology | Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.05 M
Public Float
44.65 M
Global Blood Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.41
Market Cap
$3.28 B
Shares Outstanding
56.41 M
Public Float
53.97 M

Profile

Address
171 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.gbt.com
Updated 07/08/2019
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P.

Financials

View All

Ted W. Love
President, Chief Executive Officer & Director
Wendy L. Yarno
Independent Director